stroke
Conditions
Interventions
control group:Patients in the control group received the current routine enteral nutrition care protocol of the department.
intervention group:Patients in the intervention group received preventive, structured, and proactive care based on the grading standard, in addition to routine care.
Phase 1: Observation group:None
Expert consultation panel:NA
Sponsors
Beijing Tiantan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Part I (Phase 1) and Part II (Phase 1) - Expert Consultation: 1. Hold a bachelor's degree or higher. 2. Hold an intermediate professional title or higher. 3. Have over 10 years of work experience in neurocritical care and enteral nutrition. 4. Voluntarily participate and be able to complete two rounds of the expert Delphi survey. Part I (Phase 2) - Validation of Risk Warning Criteria: 1. Stroke diagnosis meets the relevant criteria outlined in "Key Diagnostic Points for Various Cerebrovascular Diseases". 2. Aged between 18 and 80 years. 3. Diagnosed with acute cerebral infarction or intracerebral hemorrhage confirmed by head CT or MRI. 4. Score >=3 on the Nutritional Risk Screening (NRS-2002) assessment. 5. Require nasogastric tube feeding. 6. Provide signed informed consent. Part II (Phase 2) - Validation of Risk Management Protocol: 1. Stroke diagnosis meets the relevant criteria outlined in "Key Diagnostic Points for Various Cerebrovascular Diseases". 2. Aged between 18 and 80 years. 3. Diagnosed with acute cerebral infarction or intracerebral hemorrhage confirmed by head CT or MRI. 4. Score >=3 on the Nutritional Risk Screening (NRS-2002) assessment. 5. Require nasogastric tube feeding. 6. Have not developed enteral nutrition-associated diarrhea. 7. Provide signed informed consent.
Exclusion criteria
Exclusion criteria: Part I (Phase 2) - Validation of Risk Warning Criteria: 1. Patients with contraindications to enteral nutrition. 2. Patients with pre-existing diarrhea prior to initiating enteral nutrition support. 3. Patients presenting with incontinence-associated dermatitis at admission. 4. Patients with a history of gastrointestinal surgery. 5. Patients complicated by severe dysfunction of vital organs (e.g., heart, lung, liver, kidney). 6. Patients with malignancies. 7. Female patients who are pregnant, in the puerperium period, or lactating. Part II (Phase 2) - Validation of Risk Management Protocol: 1. Patients with contraindications to enteral nutrition. 2. Patients with pre-existing diarrhea prior to initiating enteral nutrition support. 3. Patients presenting with incontinence-associated dermatitis at admission. 4. Patients with a history of gastrointestinal surgery. 5. Patients complicated by severe dysfunction of vital organs (e.g., heart, lung, liver, kidney). 6. Patients with malignancies. 7. Female patients who are pregnant, in the puerperium period, or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of enteral nutrition-associated diarrhea; | — |
Secondary
| Measure | Time frame |
|---|---|
| The reliability and validity of the risk assessment tool for enteral nutrition-related diarrhea; | — |
Countries
China
Contacts
Public ContactJun Shu
Beijing Tiantan Hospital, Capital Medical University
Outcome results
None listed